Details for 2020728258

Up to date per 04.04.2026

Actions

Title / Product Name

RITUXIMAB-RESISTENTE CHIMÄRE ANTIGENREZEPTOREN UND DEREN VERWENDUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020728258

EP Publication Number

3959235

E-Number

1591860

Language

PCT Number

US20029775

Publication Date

02.03.2022 A

26.07.2023 B1

Registration Date

26.07.2023

AT Publication Date

15.08.2023

Application Date

24.04.2020

Registration Number

Priorities

26.04.2019

201962839455 P

03.04.2020

202063005041 P

IPC

C07K 14/725 20060101AFI20201030BHEP

Maximum Duration of Protection

24.04.2040

Owner

Allogene Therapeutics, Inc.210 E. Grand Avenue South San Francisco, CA 94080US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

PERTEL, Thomas Charlesc/o Allogene Therapeutcis, Inc. 210 E. Grand Avenue South San Francisco, California 94080US

SASU, Barbra Johnsonc/o Allogene Therapeutics, Inc. 210 E. Grand Avenue South San Francisco, California 94080US

LEONARD, Mark W.c/o Allogene Therapeutics, Inc. 210 E. Grand Avenue South San Francisco, California 94080US

Information about Fees